Dopo l'orario di chiusura: 4.09

Aldeyra Therapeutics Inc (ALDX)

Aldeyra Therapeutics Inc Borsa (ALDX) Ultime notizie

Aldeyra Therapeutics Inc (ALDX)

Aldeyra Therapeutics Inc Borsa (ALDX) Ultime notizie

Options Traders Expect Huge Moves in Aldeyra (ALDX) Stock - Yahoo Movies UK

Is Aldeyra Therapeutics (ALDX) Stock Outpacing Its Medical Peers This Year? - Zacks Investment Research

Is Aldeyra Therapeutics (ALDX) Stock Outpacing Its Medical Peers This Year?

Aldeyra Therapeutics, Inc (NASDAQ:ALDX) to Post Q2 2024 Earnings of ($0.15) Per Share, HC Wainwright Forecasts - Defense World

HC Wainwright Comments on Aldeyra Therapeutics, Inc's Q2 2024 Earnings (NASDAQ:ALDX) - MarketBeat

Aldeyra Therapeutics, Inc to Post FY2027 Earnings of $0.22 Per Share, HC Wainwright Forecasts (NASDAQ:ALDX) - Defense World

Investing in Aldeyra Therapeutics Inc (ALDX): What You Must Know – Knox Daily - Knox Daily

Aldeyra Therapeutics, Inc (NASDAQ:ALDX) to Post FY2027 Earnings of $0.22 Per Share, HC Wainwright Forecasts - MarketBeat

Aldeyra Therapeutics (NASDAQ:ALDX) Stock Rating Lowered by StockNews.com - Defense World

Strs Ohio Raises Holdings in Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World

Aldeyra Therapeutics Highlights Recent Preclinical Data in Obesity, Atopic Dermatitis, Pain, and Alcoholic Hepatitis ... - Business Wire

Is Aldeyra Therapeutics (ALDX) Outperforming Other Medical Stocks This Year?

Is Aldeyra Therapeutics (ALDX) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Perceptive advisors buys Aldeyra Therapeutics shares worth $833k - Investing.com Nigeria

Aldeyra (ALDX) Stock Rallies 43% in One Week: Here's Why

Aldeyra (ALDX) Stock Rallies 43% in One Week: Here's Why - Yahoo Finance

Are Medical Stocks Lagging Aclaris Therapeutics (ACRS) This Year?

Aldeyra Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying

Aldeyra stock gains as Perceptive boosts stake (NASDAQ:ALDX) - Seeking Alpha

Aldeyra stock gains as Oppenheimer upgrades (NASDAQ:ALDX) - Seeking Alpha

Aldeyra Therapeutics Unveils Reproxalap Development Update - TipRanks.com - TipRanks

Aldeyra stock gains on plans for AbbVie-partnered drug - Seeking Alpha

Aldeyra: Derisked Biotech Eyeing Path To Approval And Finalizing Deal With AbbVie (NASDAQ:ALDX) - Seeking Alpha

Painful week for individual investors invested in Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) after 28% drop, institutions also suffered losses - Simply Wall St

Aldeyra Therapeutics Inc President and CEO Todd Brady Sells Company Shares - Yahoo Finance

Here's Why You Should Invest in Aldeyra (ALDX) Stock Now

Here's Why You Should Invest in Aldeyra (ALDX) Stock Now - Yahoo Finance

Is Aclaris Therapeutics (ACRS) Outperforming Other Medical Stocks This Year?

Is Aclaris Therapeutics (ACRS) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Zacks Industry Outlook Highlights United Therapeutics, Esperion Therapeutics., Heron Therapeutics, Lyra Therapeutics and Aldeyra Therapeutics

Zacks Industry Outlook Highlights United Therapeutics, Esperion Therapeutics., Heron Therapeutics, Lyra Therapeutics ... - Yahoo Finance

5 Small Drug Stocks to Buy From a Rebounding Industry

Palatin to push through with dry eye therapy despite Phase III miss - Clinical Trials Arena

Ligand (LGND) Q4 Earnings Surpass Estimates, Stock Surges

Is Aldeyra Therapeutics (NASDAQ:ALDX) Weighed On By Its Debt Load? - Simply Wall St

Aldeyra Therapeutics Is A Strong Buy: AbbVie Agreement And Reproxalap's Prospects (ALDX) - Seeking Alpha

Alcon's dry eye drug achieves primary endpoints in Phase III trials - Clinical Trials Arena

Aldeyra Therapeutics Provides Clinical and Regulatory Update and Announces Advancement of RASP Platform in ... - Yahoo Finance

Oracle (ORCL) to Report Q2 Earnings: What's in the Cards?

Semtech (SMTC) to Release Q3 Earnings: What's in the Cards?

Should You Buy Aldeyra Therapeutics (ALDX) Ahead of Earnings?

BOX Gears Up to Report Q3 Earnings: What's in the Offing?

With FDA's inevitable rejection in hand for eye drug, Aldeyra plans speedy new trial - Fierce Biotech

What's in Store for Patterson Companies (PDCO) in Q2 Earnings?

Aldeyra and AbbVie partner for reproxalap development - Pharmaceutical Technology

Why Is Aldeyra Therapeutics (ALDX) Stock Up 40% Today? - InvestorPlace

Biotech Stock Roundup: ALDX, EVLO Down on Setback, SRRK Offers Updates & More - Yahoo Finance

Thinking about buying stock in Momentus Inc, Secoo Holding, RedHill Biopharma, Aldeyra Therapeutics, or Mereo ... - PR Newswire

Aldeyra Therapeutics stock tanks on warning that FDA will reject new drug application - Proactive Investors UK

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders of a Class Action against Aldeyra Therapeutics ... - PR Newswire

Simile a ALDX